Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) EBT Margin (2022 - 2025)

Historic EBT Margin for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to 262.47%.

  • Neuraxis' EBT Margin fell 50600.0% to 262.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 209.42%, marking a year-over-year increase of 1164500.0%. This contributed to the annual value of 266.54% for FY2024, which is 237400.0% up from last year.
  • According to the latest figures from Q3 2025, Neuraxis' EBT Margin is 262.47%, which was down 50600.0% from 193.64% recorded in Q2 2025.
  • Neuraxis' EBT Margin's 5-year high stood at 103.14% during Q2 2022, with a 5-year trough of 654.06% in Q3 2023.
  • Moreover, its 4-year median value for EBT Margin was 233.6% (2022), whereas its average is 259.1%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by -4433500bps in 2023, then surged by 3966500bps in 2024.
  • Neuraxis' EBT Margin (Quarter) stood at 186.53% in 2022, then tumbled by -66bps to 309.67% in 2023, then soared by 63bps to 116.01% in 2024, then tumbled by -126bps to 262.47% in 2025.
  • Its EBT Margin stands at 262.47% for Q3 2025, versus 193.64% for Q2 2025 and 256.5% for Q1 2025.